1. Quiñones MA, Greenberg BH, Kopelen HA, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000. 35:1237–1244.
2. Sohn JW, Shin DG, Kim DH, et al. Non-invasive parameters, including a low left ventricular ejection fraction, for predicting sudden cardiac death in Korean post myocardial infarction patients. Korean Circ J. 2006. 36:431–436.
3. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation. 1991. 83:1676–1684.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990. 322:1561–1566.
5. Mayet J, Ariff B, Wasan B, et al. Midwall myocardial shortening in athletic left ventricular hypertrophy. Int J Cardiol. 2002. 86:233–238.
6. de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol. 1994. 23:1444–1451.
7. Aurigemma GP, Gaasch WH, McLaughlin M, McGinn R, Sweeney A, Meyer TE. Reduced left ventricular systolic pump performance and depressed myocardial contractile function in patients > 65 years of age with normal ejection fraction and a high relative wall thickness. Am J Cardiol. 1995. 76:702–705.
8. Calabrò R, Pisacane C, Pacileo G, Russo MG. Left ventricular midwall mechanics in healthy children and adolescents. J Am Soc Echocardiogr. 1999. 12:932–940.
9. Slotwiner DJ, Devereux RB, Schwartz JE, et al. Relation of age to left ventricular function in clinically normal adults. Am J Cardiol. 1998. 82:621–626.
10. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American society of echocardiography's guideline and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005. 18:1440–1463.
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977. 55:613–618.
12. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992. 20:1251–1260.
13. Shimizu G, Conrad CH, Gaasch WH. Phase-plane analysis of left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy. Circulation. 1987. 75:1 Pt 2. I34–I39.
14. Yip GW, Shang Q, Tam LS, et al. Disease chronicity and activity predict subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus. Heart. 2009. 95:980–987.
15. de Simone G, Kimball TR, Roman MJ, et al. Relation of left ventricular chamber and midwall function to age in normal children, adolescents and adults. Ital Heart J. 2000. 1:295–300.
16. Park SW. Multicenter trial for estimation of normal values of echocardiograhic indices in Korea. Korean Circ J. 2000. 30:373–382.
17. Choi SH, Ha JW, Chang BC, et al. Long-term outcome of clinically insignificant aortic valve disease in patients undergoing mitral valve surgery for rheumatic heart disease. Korean Circ J. 2001. 31:1034–1041.
18. Corti R, Binggeli C, Turina M, Jenni R, Luscher TF, Turina J. Predictors of long-term survival after valve replacement for chronic aortic regurgitation: is M-mode echocardiography sufficient? Eur Heart J. 2001. 22:866–873.
19. Wandt B, Bojö L, Tolagen K, Wranne B. Echocardiographic assessment of ejection fraction in left ventricular hypertrophy. Heart. 1999. 82:192–198.
20. Seo JC, Lee MS, Chae CS, et al. Relation of hemodynamic load to left ventricular hypertrophy and performance in essential hypertension. Korean Circ J. 1993. 23:380–389.
21. Palmon LC, Reichek N, Yeon SB, et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation. 1994. 89:122–131.
22. Rademakers FE, Rogers WJ, Guier WH, et al. Relation of regional cross-fiber shortening to wall thickening in the intact heart: three-dimensional strain analysis by NMR tagging. Circulation. 1994. 89:1174–1182.
23. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics: an independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996. 93:259–265.
24. Devereux RB, de Simone G, Pickering TG, Schwartz JE, Roman MJ. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension. 1998. 31:929–936.
25. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2001. 37:1042–1048.
26. Schussheim AE, Diamond JA, Jhang JS, Phillips RA. Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol. 1998. 82:1056–1059.